{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:49:08Z","timestamp":1790617748151,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002447","name":"Catholic University of Daegu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2016R1D1A1B03933687"],"award-info":[{"award-number":["2016R1D1A1B03933687"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.cca.2018.08.022","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T12:13:19Z","timestamp":1534767199000},"page":"269-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["NLRP3 inflammasomes and NLRP3 inflammasome-derived proinflammatory cytokines in peripheral blood mononuclear cells of patients with ankylosing spondylitis"],"prefix":"10.1016","volume":"486","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7780-0167","authenticated-orcid":false,"given":"Seong-Kyu","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Jeong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Yoon","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2018.08.022_bb0005","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"Braun","year":"2007","journal-title":"Lancet"},{"issue":"Suppl. 3","key":"10.1016\/j.cca.2018.08.022_bb0010","doi-asserted-by":"crossref","first-page":"iii8","DOI":"10.1136\/ard.61.suppl_3.iii8","article-title":"Ankylosing spondylitis: an overview","volume":"61","author":"Sieper","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2018.08.022_bb0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.1780380407","article-title":"Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis","volume":"38","author":"Braun","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2018.08.022_bb0020","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/rheumatology\/41.12.1419","article-title":"Interleukin-1\u03b2 and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis","volume":"41","author":"van der Paardt","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2018.08.022_bb0025","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/art.21642","article-title":"Association of the IL1 gene cluster with susceptibility to ankylosing spondylitis: an analysis of three Canadian populations","volume":"54","author":"Maksymowych","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2018.08.022_bb0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcma.2012.05.006","article-title":"Association of serum interleukin-17 and interleukin-23 levels with disease activity in Chinese patients with ankylosing spondylitis","volume":"75","author":"Chen","year":"2012","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.cca.2018.08.022_bb0035","first-page":"621","article-title":"Elevated serum interleukin-23 levels in ankylosing spondylitis patients and the relationship with disease activity","volume":"77","author":"Ugur","year":"2015","journal-title":"Nagoya J. Med. Sci."},{"key":"10.1016\/j.cca.2018.08.022_bb0040","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.cca.2018.08.022_bb0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","article-title":"The inflammasomes: guardians of the body","volume":"27","author":"Martinon","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cca.2018.08.022_bb0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from \u03b3\u03b4 T cells, amplifying Th17 responses and autoimmunity","volume":"31","author":"Sutton","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.cca.2018.08.022_bb0055","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.4049\/jimmunol.1003597","article-title":"Caspase-1-processed cytokines IL-1\u03b2 and IL-18 promote IL-17 production by \u03b3\u03b4 and CD4 T cells that mediate autoimmunity","volume":"186","author":"Lalor","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2018.08.022_bb0060","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2018.08.022_bb0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cca.2017.09.019","article-title":"Enhanced expression of NLRP3 inflammasome-related inflammation in peripheral blood mononuclear cells in Sj\u00f6gren's syndrome","volume":"474","author":"Kim","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2018.08.022_bb0070","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/annrheumdis-2013-203276","article-title":"Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment","volume":"73","author":"Mathews","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2018.08.022_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.cca.2018.08.022_bb0080","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/03009742.2013.779020","article-title":"Genetic variants in CARD8 but not in NLRP3 are associated with ankylosing spondylitis","volume":"42","author":"Kastbom","year":"2013","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.cca.2018.08.022_bb0085","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3346\/jkms.2013.28.9.1289","article-title":"Caspase-1 level in synovial fluid is high in patients with spondyloarthropathy but not in patients with gout","volume":"28","author":"Son","year":"2013","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.cca.2018.08.022_bb0090","doi-asserted-by":"crossref","unstructured":"A. Bal, E. Unlu, G. Bahar, E. Aydog, E. Eksioglu, R. Yorgancioglu, Comparison of serum IL-1\u03b2, sIL-2R, IL-6, and TNF-\u03b1 levels with disease activity parameters in ankylosing spondylitis. Clin. Rheumatol. 26 (2007) 211\u2013215.","DOI":"10.1007\/s10067-006-0283-5"},{"key":"10.1016\/j.cca.2018.08.022_bb0095","first-page":"40","article-title":"The expression of proinflammatory cytokines and intracellular minerals in patients with ankylosing spondylitis","volume":"23","author":"Lee","year":"2009","journal-title":"Formos. J. Rheumatol."},{"key":"10.1016\/j.cca.2018.08.022_bb0100","first-page":"1603","article-title":"Interleukin 1 polymorphisms in patients with ankylosing spondylitis in Korea","volume":"35","author":"Kim","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cca.2018.08.022_bb0105","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cca.2018.08.022_bb0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.0105-2896.2004.00214.x","article-title":"IL-12 and IL-23: master regulators of innate and adaptive immunity","volume":"202","author":"Langrish","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cca.2018.08.022_bb0115","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cca.2018.08.022_bb0120","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/ard.2004.023176","article-title":"Open label trial of anakinra in active ankylosing spondylitis over 24 weeks","volume":"64","author":"Haibel","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2018.08.022_bb0125","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/ard.2004.020800","article-title":"Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study","volume":"63","author":"Tan","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2018.08.022_bb0130","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","article-title":"Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Baeten","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2018.08.022_bb0135","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2018.08.022_bb0140","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/art.20115","article-title":"Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade","volume":"50","author":"Buch","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2018.08.022_bb0145","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2018.08.022_bb0150","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s10495-014-1057-1","article-title":"Oxidative stress by monosodium urate crystals promotes renal cell apoptosis through mitochondrial caspase-dependent pathway in human embryonic kidney 293 cells: mechanism for urate-induced nephropathy","volume":"20","author":"Choe","year":"2015","journal-title":"Apoptosis"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118304169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118304169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:02:01Z","timestamp":1762113721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898118304169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":30,"alternative-id":["S0009898118304169"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2018.08.022","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NLRP3 inflammasomes and NLRP3 inflammasome-derived proinflammatory cytokines in peripheral blood mononuclear cells of patients with ankylosing spondylitis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2018.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}